DatasetName,AKAP1_C(151) AKAP1_S(3) AKAP1_S(330) AKAP1_S(4) AKAP1_S(440) AKAP1_T(407),AKAP1_S(105) AKAP1_S(107) AKAP1_S(108) AKAP1_S(141) AKAP1_S(142) AKAP1_S(150) AKAP1_S(151) AKAP1_S(161) AKAP1_S(169) AKAP1_S(231) AKAP1_S(238) AKAP1_S(309) AKAP1_S(429) AKAP1_S(441) AKAP1_S(444) AKAP1_S(445) AKAP1_S(583) AKAP1_S(586) AKAP1_S(592) AKAP1_S(600) AKAP1_S(73) AKAP1_T(136) AKAP1_T(530) AKAP1_T(533) AKAP1_T(590) AKAP1_T(66) AKAP1_T(70)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,0.5219901314538818
FSO2013_Ratio M/L normalized Rep3,,0.5000052124415119
SR2019_MCF7_Biol_repl_3,,0.5026445793836708
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,0.4909837234480613
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,0.4985926048805152
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,0.5015809530193158
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,0.4914194537616541
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,0.5052819133050194
SR2019_MDAMB231_Biol_repl_4,,0.49701667993622656
GF2025_P2_Sph,,0.5045416185749806
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,,0.5051494675178243
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,0.5028921003961755
RB2022_5_PreEndurance,,0.509427671519584
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,,0.48945306921935655
WZ2023_Pu_010_30min,0.6790276884646457,0.509590257549095
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,0.4999673382960323
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.4959140182760393
RB2022_8_RecoveryEndurance,,0.49231053604018565
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,0.4855669384389836
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,0.5015139539375003
RB2022_5_PreSprint,,0.5000907888688416
PG2020_Intensity 8h_C,,0.4824882486745716
AH2018_SILAC_MR_2_N,,0.49904061873399846
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,0.4983298023819223
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,0.49987135812136657
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,,0.5147976874195545
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,0.4983951336657617
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,0.49808098663186556
GF2025_P6_Sph,,0.48316294819619626
RB2022_2_PreSprint,,0.5062673558153984
ZX2022_CB treated Replicate 3,,0.48965798278957173
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.6788124577069325,0.5116003586431487
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,
WZ2023_Pu_005_10min,0.677456519633384,0.5086162543718488
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,0.49811181257078146
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,0.4998285007491668
WZ2023_Pu_025_30min,0.6773367844043306,0.5135575605553907
AH2018_SILAC_MR_2_X,,0.5011315147641894
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,0.5086088007733705
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,,0.4827726545108131
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,0.5281948080723091
EJN2021_3_Rest_Basal,,0.48416640214044665
CR2017_Ratio Replicate 1.3,,0.4906347972375534
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,0.5022311435023847
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,0.5020843863478909
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,0.503335498133203
AH2018_LFQ_1_C,,0.49820824869443675
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.6776805622468475,0.5121086701808655
CK2022_11 40-1,,0.498782301289389
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,0.5020741743734326
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,0.5070332620956894
FSO2013_Ratio H/L normalized Rep2,,0.5044075868748797
WZ2023_Pu_005_20min,0.6764826339130328,0.5094928092033425
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,0.47491871301116667
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,0.5003514303665756
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,0.49219115661760254
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,0.49721135982558595
RCJD2014_20min_mean,,0.5027240085587485
FR2021_Norm.Intensity.H,,0.5026951897915478
RB2022_2_PreStrength,,0.511642358467843
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,0.49566162419929366
CK2022_1 200-1,,0.4934981720869108
PG2020_Intensity Mock_10h_D,,0.49760552313973594
SR2019_MCF10A_Biol_repl_2,,0.49560301275413393
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,0.5017412217758399
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,0.49837779576586255
RCJD2014_5min_1,,0.4980811674664487
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,0.4999390349637927
PG2020_Intensity 2h_C,,0.49722688318962227
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,0.48989987462791695
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,0.5047867689803943
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,,0.4972005662032894
CK2022_3 40-1,,0.4994908466155348
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,,0.5072955476566006
HH2022_Reporter intensity 8,,0.5029385616008187
ZQ2022_N2,,0.5036423760592774
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,0.5082383653409273
EJN2021_5_Rest_Basal,,0.4849766503337627
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,0.5023161003806698
YA2020_Reporter_intensity_Normal_No.1,,0.5070028720374807
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,0.5237142859585735
RB2022_1_PostEndurance,,0.5168589480784622
CR2017_Ratio Replicate 3,,0.5172274831203865
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,0.5016740795365207
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,0.4797056904551003
HS2024_8_I_T3,,
CF2017_EOC 3,,0.5022253524986376
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.6791439535102556,0.5105043184861449
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,0.49919112885945366
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,0.49872987851976724
KS2014_Intensity N3,0.6751954684083188,0.523089518183487
RB2022_4_RecoveryEndurance,,0.5071251477339883
RB2022_5_RecoveryEndurance,,0.5088481783973331
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,0.5015840203125056
FSO2013_Ratio H/M normalized Rep2,,0.5008141695451698
RAM2015_Log2 A,,0.5017869921373429
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,0.4949245144667333
KS2014_Intensity E15_2,,0.4982318958225671
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,0.5061558459686416
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,0.49772403227107526
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,,0.5023165838565131
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,0.49477651356422087
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,0.5381690545667849
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,0.4898309445439398
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.6721594923693237,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,0.5007466701716394
AH2018_SILAC_IT_3_X,,0.5023269931955325
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,0.48954533813942663
FSO2013_Ratio M/L normalized Rep2,,0.505899501555956
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,0.5046084407368929
SR2019_HCC1954_Biol_repl_2,,0.49755897994519294
CK2022_14 40-1,,0.5001137699754679
RB2022_6_PreSprint,,0.5020578843493054
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,0.4985925194533727
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,0.49939586962672683
DL2023_control-1,,
AR2021_ALG 10 μM,,0.5110782094721988
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,0.5062860861063193
EJN2021_4_Rest_Ins,,0.48996797600227393
RN2012_H05,,0.4977944293048922
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,0.5063873457972305
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,0.5228670456053208
EJN2021_1_Rest_Ins,,0.4757609996989091
HH2022_Reporter intensity 3,0.6768931546961005,0.49999871199734836
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,0.5042881449155849
JW2021_After_3,,
GF2025_P8_Sph,,0.49806744660624774
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,0.5027608763049101
CK2022_11 200-1,,0.49499215910135774
CK2022_12 200-1,,0.49658489800148503
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,0.6765032352050805,0.5105805637487683
AH2018_TMTMS2_2_N,,0.48229436151327015
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.671452499918289,
AH2018_TMTMS3_Pool,,0.5041773756196355
KS2014_Intensity N4,0.6768411548614187,0.5216964340000856
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,0.49810202418236454
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,0.4990582829246692
CK2022_14 200-1,,0.49910750840197027
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,0.5379099515751613
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,0.49962022725032235
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,,0.5025500189968088
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,0.4919068656157586
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,0.4983088671890301
GF2025_P1_Adh,,0.48738824695621935
GF2025_P1_Sph,,0.5076545468955502
EJN2021_5_Ex_Basal,,0.4920196034413798
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.6795345512922651,0.5128838747286443
CF2017_EOC 1,,0.5008788015909199
CK2022_3 200-1,,0.494611461260287
AH2018_LFQ_IT_3_C,,0.5018537962574511
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,0.4966073924576989
RB2022_3_RecoverySprint,,0.49500633060833127
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,0.499171094661729
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,0.5042319946350284
CK2022_2 40-1,,0.4996290988196796
RB2022_1_PostSprint,,0.51085297099532
CK2022_4 200-1,,0.49453784066924916
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,0.49841387664115755
AR2021_ALG 1 μM,,0.5109238059687898
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,0.4987832306003572
EJN2021_1_Rest_Basal,,0.48750967307435356
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,0.5053136290497114
CR2017_Ratio Replicate 3.2,,0.5007876981439722
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,0.5064979965487998
CK2022_9 16-1,,0.4954379097188219
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,0.49981944247154564
CK2022_13 200-1,,0.49899632983367753
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,0.4989172153700491
CK2022_16 16-1,,0.4992552984458466
FS2019_db/db3,,
CK2022_15 40-1,,0.500330929751163
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.6766847956027596,0.5084518928192137
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,0.5020566031364494
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,,0.5059843364292262
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,,0.49838426905978583
KBE2022_Log2_Ex_27_U,,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,0.49700433040682834
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,0.5159071965687818
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,0.5011712355227134
YA2020_Reporter_intensity_Normal_No.4,,0.503185810675886
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,0.4927096957130403
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,0.49472496823291
RN2012_L13,,0.5075110421022565
LG2023_Control-1_intensity,,0.49609668383283356
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,0.49452595686089224
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,0.5013087148943778
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,0.4984794013903345
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,0.4944141903841685
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,0.5160806701786351
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,0.493427525075472
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,0.4997945854186809
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,0.4938208131024435
AH2018_TMTMS2_3_X,,0.48684307186923986
GF2025_P3_Adh,,0.5180635676312529
SR2019_JIMT1_Biol_repl_2,,0.49950034834345886
AH2018_TMTMS2_1_C,,0.4869185264888519
RM2024_Intensity D0-1___2,,
LY2019_P4+,,0.4982222213093465
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,0.5222017419093835
LG2023_GSK3α-3_intensity,,0.49870145059535836
YA2020_Reporter_intensity_Cancer_No.1,,0.4796544898592298
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,0.5017557644936856
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,0.5056962992477102
LG2023_Control-2_intensity,,0.5019224025999636
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,0.4989012774837127
RB2022_5_RecoverySprint,,0.5129371669544975
RB2022_7_RecoverySprint,,0.5094930760369041
YA2020_Reporter_intensity_Normal_No.3,,0.504671917689718
HS2024_8_B_T2,,
AH2018_LFQ_1_X,,0.4974970931391167
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,0.4982974365627737
FR2021_Norm.Intensity.M,,0.5022988494443283
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.6778521867273853,0.5301783078924925
HH2022_Reporter intensity 1,0.6772965374299834,0.5005668739671274
HH2022_Reporter intensity 2,0.6770263539256728,0.5001841505425563
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,0.5069315755839001
SR2019_MCF7_Biol_repl_1,,0.5037021284232422
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,0.48966725396713184
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,0.5029019182792113
CR2017_Ratio Replicate 2,,0.4927430022110186
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,0.4999337775897643
AR2021_KD 72h,,0.5073798749586275
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,0.5102468371297889
KBE2022_Log2_Ex_9_U,,
AH2018_SILAC_M_3_N,,0.5024090230137503
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,0.4958853307328411
CF2017_OSE 29,,0.49628368763025904
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,0.5026712662941135
RN2012_L12,,0.5006149555874293
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,0.5025844320368302
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,0.5031294803475591
FSO2013_Ratio H/M normalized Rep1___1,,0.5006936616698872
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,0.5025434389741623
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,0.5010583053718259
RB2022_7_RecoveryEndurance,,0.4928171474022203
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,0.48393320857747574
TM2022_S2.12h.B,,
RN2012_L15,,0.49217084632447505
KS2014_Intensity pY_PV3,,0.49129150893359286
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,0.5024410677765785
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,,0.5143421797446988
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,,0.497057404493914
CK2022_5 200-1,,0.4967430093212868
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,0.504479930701799
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,0.5201118392293245
AH2018_LFQ_2_C,,0.5012150698886466
AH2018_SILAC_MR_1_X,,0.49431747634329115
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,
AH2018_SILAC_3_C,,0.5025866494689171
EJN2021_5_Rest_Ins,,0.4857022842117439
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,0.500300338318251
CK2022_4 16-1,,0.4969318441562319
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,0.5042881278266734
EJN2021_2_Ex_Ins,,0.4900349666880529
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,0.49913863770828076
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,0.5098841962863132
FSO2013_Ratio H/L normalized Rep3,,0.5021259210989517
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,,
AH2018_SILAC_IT_2_N,,0.5061778437906171
AH2018_SILAC_IT_1_X,,0.5015748087773285
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,0.4863151248235464
WZ2023_Pe_025_20min,0.6766974012666721,0.5107871031293767
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,0.49966064832257406
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,,0.48623621348512835
RN2012_H06,,0.4879230003013948
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.6747637455786563,0.5125262244346538
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,0.49949969921532317
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,,0.45258325895752
WZ2023_Su_025_10min,0.6773880012959168,0.5078784260772112
AH2018_LFQ_IT_4_X,,0.5022349168765499
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,0.5059003881229719
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.6750917404496621,0.5087058150116691
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,0.5031162234242134
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,0.4988437608544359
EP2017_Pervanadate R#1 log2 ratio,,0.5125475020471447
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,0.505365030578573
KS2014_Intensity,,0.52291731915959
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,,0.5000459147826132
LY2019_P7+,,0.4950751680517899
EP2017_Untreated R#1 normalized log2 ratio,,0.5165676704217186
RN2012_L10,,0.4969412104267138
PG2020_Intensity 4h_C,,0.4991110734793639
EP2017_Mitotic R#3 normalized log2 ratio,,0.49959510034920485
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,
RB2022_8_PostStrength,,0.5232397921681479
AH2018_SILAC_IT_2_X,,0.5017322554987882
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,,0.5030562707352344
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,0.4999475139445057
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,0.5032073804395686
GF2025_P9_Sph,,0.4924364897087004
CK2022_6 200-1,,0.49642820905708474
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,0.5093336225586704
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,0.4908919172159925
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,0.49385039093269617
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,0.4964470018300161
PG2020_Intensity 2h_D,,0.49042788906934714
EP2017_Untreated R#3 normalized log2 ratio,,0.5077000638878496
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,,0.4965748611104716
KS2014_Intensity pY_C4,,0.4995574796353609
CR2017_Ratio Replicate 3.5,,0.4863585052689672
RB2022_7_PostEndurance,,0.5094191130685717
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,,0.5036960349237244
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,0.4981968306918069
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,0.5018563259821561
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,0.491254934092127
FR2021_Intensity.M,,0.5022988494443283
RB2022_2_PostSprint,,0.5182611115939606
AH2018_SILAC_MR_3_N,,0.500464232271238
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,0.49798039792625814
PG2020_Intensity CT_C,,0.5071058368052568
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,0.4958526169043105
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,,0.5082553224762901
RB2022_2_PostStrength,,0.506379885462056
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,0.5296630649286299
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,0.5022416180363172
FR2021_Norm.Intensity.G,,0.5025515973168523
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,0.4990965567725911
CR2017_Ratio Replicate 2.3,,0.48422100588201067
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,0.5037484990393815
YA2020_Reporter_intensity_Normal_No.2,,0.501794583278934
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,0.5033038198858392
RAM2015_Log2 C,,0.5027872259452946
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,0.5039984099127518
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,,0.4962857856789135
RAM2015_Log2 B,,0.4990560778672763
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,0.48490761421184814
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,,0.4991751001555568
WZ2023_Su_025_30min,0.6751391130840756,0.5091126094976803
AH2018_LFQ_4_N,,0.4981559178425365
CR2017_Ratio Replicate 1.2,,0.4969642699558679
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,0.5080480019384931
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,,0.4958528900839277
RB2022_7_PreEndurance,,0.4951215699599317
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,0.5019831286420713
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,0.5230471535593463
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,0.5092997751127945
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,0.5043590953726004
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,0.5032572090910966
KS2014_Intensity C5,,0.5046861713525618
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,0.5099158303884587
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,0.5209943917956403
RB2022_3_PostStrength,,0.5280751965936819
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,0.4986179895539547
AH2018_LFQ_M_4_N,,0.4997542377608886
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,0.4965239765629857
AH2018_LFQ_2_X,,0.5003034351786853
PG2020_Intensity 2h_B,,0.4987168206195716
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,0.5182494698056965
KS2014_Intensity E15_3,,0.5112955230796132
GF2025_P3_Sph,,0.49651737323506856
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,0.5015858242574929
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.68083459182568,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,0.5065289349766529
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,0.5004964476226971
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,,0.47538433846138917
ZQ2022_N1,,0.5019663196726349
LY2019_P6-,,0.5067251231964722
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,0.5014817316141955
AH2018_LFQ_3_N,,0.5011235933409213
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,0.5019370568210197
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,0.5072584170381176
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,0.5011120374269973
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,0.5079734174492715
SR2019_BT549_Biol_repl_2,,0.49861880769556843
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,0.5048218687554448
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.6763602130756804,0.5072832884460703
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,0.49974112016332684
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,0.5029031249891999
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,0.500330929751163
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,0.4891890309887901
PG2020_Intensity 10h_D,,0.5006554260120567
RB2022_8_PreEndurance,,0.4957194661582787
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,0.4849319032661928
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,0.47962325143053297
EP2017_Pervanadate R#3 log2 ratio,,0.5141651002077852
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,0.49597991141484293
RB2022_6_PostStrength,,0.49549553865236223
AH2018_SILAC_MR_3_C,,0.5005006811248077
AH2018_LFQ_M_4_C,,0.5014608588161055
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,0.5032357789989006
CK2022_6 40-1,,0.501077735496837
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,,0.4915360205221549
FR2021_Intensity.A,,0.5023643373586003
EJN2021_3_Ex_Ins,,0.4864015896836894
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.6788618605923592,0.5113847237183317
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,0.4863272740779878
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,0.501411068669721
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.67808681697668,0.5118727948803801
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,0.5094700225531498
RB2022_1_RecoveryStrength,,0.5057662104158782
SR2019_HCC1954_Biol_repl_4,,0.49145294673473744
FR2021_Norm.Intensity.N,,0.49659602194269675
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,0.48987249638836117
RB2022_4_PreSprint,,0.5023552620730426
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,0.5080592189938571
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,0.5086506841804217
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,0.49858034435216864
LY2019_P8+,,0.5007997933353511
RB2022_2_RecoveryEndurance,,0.5000064678935243
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,0.5181215639798372
KS2014_Intensity pY_PV1,,0.4975981195116797
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,0.5023841981331841
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.6822837618043374,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,0.4986418805576111
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,0.497106313016953
LY2019_P2-,,0.5077250703731884
AH2018_LFQ_IT_1_X,,0.501125881463295
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,0.5064516339388865
WZ2023_Pe_005_20min,0.6775563920982878,0.5118818070430848
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,0.49560776349282665
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,0.4993044544705696
SR2019_MCF10A_Biol_repl_4,,0.4997773147614055
KS2014_Intensity pY_C5,,0.4990679275589894
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,
AH2018_TMTMS3_3_N,,0.5076934599222065
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,0.49658699844896786
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,0.49912525839323585
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,,0.5031264883831802
KBE2022_Log2_Ex_36_T,,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.6771806228080046,0.5078761918701753
KS2014_Intensity C2,,0.5172148546294344
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,,0.49480348923523065
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,0.49474633994007927
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,,0.5257353431736106
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,,0.4796445762324629
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,0.519677244714685
ZQ2022_C3,,0.5008417174814245
EJN2021_3_Rest_Ins,,0.4837750854002588
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,0.5171767491985371
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.6763360997978731,0.5088334291050381
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,0.496461024054681
HS2024_5_I_T3,,
KS2014_Intensity N1,0.67891670411228,0.5270742902013132
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,,0.4817115058311391
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,0.49744440064295375
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,0.49850374293808325
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,0.5015993748212001
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,0.5027143152700375
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,0.49529317796314765
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,,0.5029271982885025
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,0.5019473908569873
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,0.49127383028099403
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.6765332087979954,0.5115288398950596
KBE2022_Log2_Ex_29_U,,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,,0.5035076826917759
AH2018_LFQ_IT_4_N,,0.5023159248856791
CK2022_15 200-1,,0.4992732470477372
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,0.49913531086326585
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,,0.4935589865340474
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.6755751899046533,0.5085891519653705
RN2012_H01,,0.4977982606478823
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,0.4900607307116874
KS2014_Intensity pY_E5_3,,0.4982853848165282
MM2018_Ratio H/L replicate 3,,0.495635957881343
EP2017_Pervanadate R#1 normalized log2 ratio,,0.5130899842698982
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,,0.5123553729759874
KBE2022_Log2_Ex_44_U,,
WZ2023_Pe_010_20min,0.6774846209543443,0.5128685645244307
KS2014_Intensity pY_C6,,0.49926237211504754
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,0.5043503095234612
RB2022_3_PreStrength,,0.5004804555736759
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,0.5001685612690691
KS2014_Intensity C1,,0.5249641404259519
FSO2013_Ratio H/M normalized Rep3___1,,0.4999549466571497
AH2018_SILAC_M_3_C,,0.502668789129171
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,0.5019786224429147
AH2018_SILAC_M_2_X,,0.49974204729330796
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.6762039135484367,0.509325769032875
PG2020_Intensity 6h_C,,0.5155894874171246
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,0.5031808385316661
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,0.48793697495871063
CK2022_15 16-1,,0.49876675493051903
CK2022_3 16-1,,0.4960103749232435
LY2019_P4-,,0.49825145568067913
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,0.49076599464515475
HS2024_3_I_N2,,
GF2025_P8_Adh,,0.5190247975227985
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,0.5066044870092206
CK2022_10 16-1,,0.49586761784137295
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.6792765467191236,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,0.5061848605635384
EJN2021_2_Ex_Basal,,0.48732536033430457
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,0.4994105557758215
AR2021_L41 10 μM,,0.49027331851648437
CF2017_EOC 2,,0.502038708574275
RB2022_6_PostEndurance,,0.5035081241829559
AH2018_SILAC_1_N,,0.501583342012527
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,0.5004895003338552
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,0.49799156747178935
ZX2022_CB treated Replicate 1,,0.48971764462011386
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.6775894680576465,0.4998593278299608
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,0.5028098048273265
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,0.4890206004477124
AR2021_L41 1 μM,,0.4972182416361496
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,0.48166351407337865
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,0.4908516941419031
KS2014_Intensity C4,,0.5140388570595593
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,0.4961040713442478
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,0.5006042684520773
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,0.5002897098110365
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,0.5093287762447883
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,0.500521936040089
AH2018_SILAC_IT_3_C,,0.504018448634902
WZ2023_Pu_025_10min,0.680630958176152,0.511146142777658
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,0.5089616900195497
FSO2013_Ratio M/L normalized Rep3___1,,0.49992247777798443
SR2019_JIMT1_Biol_repl_4,,0.5010287276250222
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,0.49901163805831783
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.6758841398534862,0.5133305827336708
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,0.5027491311389595
KS2014_Intensity C6,,0.5156882585120689
ZQ2022_N3,,0.49965199081547346
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,0.49893836844886913
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,0.49274525944931846
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,0.5004269914949733
AH2018_SILAC_IT_2_C,,0.5036684496274185
CK2022_5 40-1,,0.5008314966488405
AH2018_LFQ_3_X,,0.5008175985270493
UK2020_UA_3,,
LY2019_P7-,,0.4951220310220241
GF2025_P5_Adh,,0.5045610266119134
RB2022_1_PostStrength,,0.520908081664023
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,0.5021319431933539
SR2019_HCC1954_Biol_repl_3,,0.49181918229149907
CR2017_Ratio Replicate 2.2,,0.4849322282579711
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,0.4957689866870788
ZQ2022_C1,,0.5000769497314357
CR2017_Ratio Replicate 2.1,,0.5140313575758607
PG2020_Intensity CT_B,,0.5014426716242762
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,0.4994773065736479
KS2014_Intensity pY_E5_1,,0.4983871197496156
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,0.5060033143843287
AH2018_LFQ_3_C,,0.49538191202618725
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.5016667594688514
YA2020_Reporter_intensity_Cancer_No.4,,0.5076052030436768
KS2014_Intensity pY_E5_2,,0.49937450029415975
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,0.5202943339119888
RB2022_2_PreEndurance,,0.5061035531675642
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,0.5026951897915478
CK2022_14 16-1,,0.498179301006721
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,0.4962815920227225
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,,0.5012853474661122
AH2018_TMTMS2_1_X,,0.4866471247416225
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,0.49822279331548386
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,0.4826731248816735
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,0.5002329752941793
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,0.49980376612881683
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,0.4977897612351442
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,
HS2024_4_I_T3,,
AH2018_SILAC_1_X,,0.5011217771651385
PG2020_Intensity 10h_B,,0.5036607185303179
AH2018_TMTMS3_1_X,,0.500947823990754
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,0.5031890496749444
SR2019_HCC1419_Biol_repl_3,,0.49675601793692764
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,,0.489333319931345
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,0.5004403098606196
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,,0.502892881172759
AS2011_Ratio H/L Normalized RNAi_2_1,,
